Related Experiment Video
Updated: Jul 9, 2026

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
Published on: February 12, 2016
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans
Karl Georg Haeusler1, Wolf U H Schmidt, Fabian Föhring
1Berlin Neuroimaging Center and Department of Neurology, Charité - University Medicine Berlin, Berlin, Germany. georg.haeusler@charite.de
Insights
Ischemic stroke triggers immediate immune suppression in humans, impacting lymphocyte counts and immune cell function. This post-stroke immunodepression is linked to stroke severity and predicts infection risk.
Area of Science:
- Neuroscience
- Immunology
- Clinical Medicine
Background:
- Previous research indicated ischemic stroke induces a prolonged, stress-mediated immunosuppressive state in mice.
- This study investigates the human relevance of post-stroke immunodepression.
Purpose of the Study:
- To prospectively examine if ischemic stroke in humans leads to immune suppression.
- To identify predictors of post-stroke complications like nosocomial infections.
Main Methods:
- Head magnetic resonance imaging (MRI) was used to assess stroke severity.
- Standardized immunoassays were employed to measure immune cell function (lymphocytes, monocytes, T helper type 1 cells).
- National Institute of Health Stroke Scale (NIHSS) scores and ex vivo tumor necrosis factor alpha (TNF-α) release were analyzed.
Main Results:
- Acute stroke patients (n=40) exhibited reduced lymphocyte counts and deactivated monocytes and T helper type 1 cells compared to healthy volunteers (n=30).
- Immunosuppression severity correlated with clinical deficit and infarction size.
- NIHSS score and monocytic TNF-α release predicted nosocomial infections, particularly in older patients.
Conclusions:
- Ischemic stroke causes immediate suppression of cell-mediated immune responses in humans.
- Post-stroke immune suppression is a significant factor influencing patient outcomes and infection risk.
Background:
We have recently shown that ischemic stroke causes a stress-mediator-induced long-lasting immunodepressive state in mice.
Methods:
Using head magnetic resonance imaging and standardized immunoassays, we prospectively investigated whether poststroke immunodepression is also seen in humans.
Results:
Compared to healthy volunteers (n = 30), a rapid depression of lymphocyte counts and a functional deactivation of monocytes and T helper type 1 cells was observed in acute stroke patients (SP; n = 40). Immunodepression was more pronounced in patients with severe clinical deficit or large infarction. On admission the combination of monocytic tumor necrosis factor alpha release ex vivo and the National Institute of Health Stroke Scale score were the best predictors for nosocomial infection, preferentially affecting older SP.
Conclusion:
Our data provide evidence for an immediate suppression of cell-mediated immune responses after ischemic stroke in humans.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Encephalitis ll: Pathophysiology
Ischemic Stroke l: Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cellular Injury IlI: Cellular Death
Myocarditis I: Introduction

